Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

SATELLITE G BLOOD GLUCOSE MONITORING SYSTEM

K-Number: K896951 · 1990-02-26

ApplicantMedisense, Inc.
Decision Date1990-02-26
Product CodeCGA
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

SATELLITE G BLOOD GLUCOSE MONITORING SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Medisense, Inc.. It received FDA 510(k) clearance on 1990-02-26 under 510(k) number K896951. The device is classified under product code CGA. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the SATELLITE G BLOOD GLUCOSE MONITORING SYSTEM?

SATELLITE G BLOOD GLUCOSE MONITORING SYSTEM is a medical device that received FDA 510(k) clearance on 1990-02-26. The listed applicant is Medisense, Inc.. The 510(k) number is K896951.

When did SATELLITE G BLOOD GLUCOSE MONITORING SYSTEM receive FDA 510(k) clearance?

SATELLITE G BLOOD GLUCOSE MONITORING SYSTEM received FDA 510(k) clearance on 1990-02-26, under 510(k) number K896951.

Who is the listed applicant for SATELLITE G BLOOD GLUCOSE MONITORING SYSTEM?

The FDA 510(k) record lists Medisense, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for SATELLITE G BLOOD GLUCOSE MONITORING SYSTEM?

The FDA product code for SATELLITE G BLOOD GLUCOSE MONITORING SYSTEM is CGA.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Medisense, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K983504PRECISION XTRA ADVANCED DIABETES MANAGEMENT SYSTEM, PRECISION BLOOD GLUCOSE TEST STRIPS, PRECISION XTRA B-KETONE TEST STK982303PRECISION PCX POINT OF CARE MANAGEMENT SYSTEM , QC MANAGER DATA MANAGER SYSTEM, PRECISION G PLUS BLOOD GLUCOSE TEST STK983253PRECISION A1C HOME HBA1C SAMPLE COLLECTION KITK971812PRECISION QID BLOOD GLUCOSE TEST STRIP, PRECISION G BLOOD GLUCOSE TEST STRIPK963676PRECISION G BLOOD GLUCOSE TESTING SYSTEMK962295PRECISION QID BLOOD GLUCOSE TEST STRIP

View all 15 devices →

Related Devices (Code: CGA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K252488ABL90 FLEX PLUS SystemRadiometer Medicals ApsK210933YSI 2900C Biochemistry AnalyzerYsi, Inc.K220328EasyStat 300Medica CorporationK223179Cholestech LDX ™ SystemAlere San Diego, Inc.K223755i-STAT G cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.K223710i-STAT CG8+ cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑